Feedback / Questions
anitocabtagene autoleucel (CART-ddBCMA) - Arcellx, Gilead
https://www.businesswire.com/news/home/20251206049158/en/Kite-Announces-New-Data-for-Pivotal-iMMagine-1-Study-at-ASH-2025-Highlighting-Anito-cels-Opportunity-in-Relapsed-or-Refractory-Multiple-Myeloma
Dec 6, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next